11.10
0.45%
-0.0501
After Hours:
11.10
0.000100
+0.00%
Bannix Acquisition Corp stock is traded at $11.10, with a volume of 16,705.
It is down -0.45% in the last 24 hours and down -0.09% over the past month.
Bannix Acquisition Corp is a blank check company.
See More
Previous Close:
$11.15
Open:
$11.1326
24h Volume:
16,705
Relative Volume:
1.59
Market Cap:
$45.31M
Revenue:
-
Net Income/Loss:
$65,400
P/E Ratio:
739.99
EPS:
0.015
Net Cash Flow:
$-1.12M
1W Performance:
-0.54%
1M Performance:
-0.09%
6M Performance:
-0.54%
1Y Performance:
+4.22%
Bannix Acquisition Corp Stock (BNIX) Company Profile
Name
Bannix Acquisition Corp
Sector
Industry
Phone
(201) 712-9800
Address
300 TICE BLVD, WOODCLIFF LAKE
Bannix Acquisition Corp Stock (BNIX) Latest News
James E. Flynn Buys 70,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock - Defense World
BANX stock touches 52-week high at $20.8 amid robust growth - Investing.com Canada
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India
Positive Ascendis data threatens BioMarin's lead in achondroplasia - The Pharma Letter
Banzai International, Inc. (NASDAQ:BNZI) Sees Large Growth in Short Interest - Defense World
Ascendis Challenges BioMarin, But Market Response Seems Excessive (NASDAQ:BMRN) - Seeking Alpha
Ascendis trial data piles pressure on BioMarin - BioPharma Dive
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity - Pharmaceutical Technology
Bicara Therapeutics raises $362 million in Nasdaq debut - The Pharma Letter
BANPU Surges 6% Following NatGas Unit Launching IPO in NYSE - KAOHOON INTERNATIONAL
Bannix Acquisition Corp. Strives to Secure VisionWave Merger - TipRanks
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination - EIN News
U.S. Markets Finished Mixed Monday As Carvana Led, BioMarin Pharmaceutical Lagged - Barron's
Bicara Therapeutics Announces Closing of $362 Million - GlobeNewswire
Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term - Yahoo Finance
BioMarin off 17% as Ascendis data seen as threat to Voxzogo - Seeking Alpha
Ascendis rises on positive trial data for dwarfism therapy - XM
Banzai International Inc’s latest rating changes from various analysts - Knox Daily
(BNIX) On The My Stocks Page - Stock Traders Daily
Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 By Investing.com - Investing.com Canada
Bicara Therapeutics Rises 39% in Debut on Nasdaq - MarketWatch
Bicara, MBX Bio lead gainers among biotech IPOs (NASDAQ:BCAX) - Seeking Alpha
TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - MSN
TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - Reuters
Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 - Investing.com India
TPG-backed Bicara Therapeutics raises $315 mln in US IPO - Reuters
Bannix Acquisition Corp. extends business combination deadline - Investing.com
Bannix Acquisition Corp. extends business combination deadline By Investing.com - Investing.com Australia
Bannix Acquisition Corp. extends business combination deadline By Investing.com - Investing.com Canada
BNIX stock touches 52-week high at $11.2 amid market optimism - Investing.com Australia
BNIX stock touches 52-week high at $11.2 amid market optimism - Investing.com India
(BNIX) Investment Analysis - Stock Traders Daily
Bannix Acquisition Corp. Extends Deadline for Business Deal - TipRanks
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination - StockTitan
BNIX stock touches 52-week high at $11.2 amid market optimism - Investing.com
BNIX stock touches 52-week high at $11.2 amid market optimism - Investing.com Canada
BNIX stock touches 52-week high at $11.2 amid market optimism - Investing.com UK
Stock Market Movers Today • Top Gainers & Losers - Benzinga
How the (BNIX) price action is used to our Advantage - Stock Traders Daily
Long Term Trading Analysis for (BNIX) - Stock Traders Daily
Bannix Acquisition Corp. Extends Merger Deadline with Sponsor Support - TipRanks
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination - WICZ
Bannix Acquisition Corp. Announces Monthly Extension To Complete Its Initial Business Combination To March 14, 2024 - Quantisnow
(BNIX) Proactive Strategies - Stock Traders Daily
Top Performing Stocks • Benzinga - Benzinga
When the Price of (BNIX) Talks, People Listen - Stock Traders Daily
Bannix Acquisition Corp. Extends Deadline for Strategic TransactionTipRanks.com - TipRanks
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination - GlobeNewswire Inc.
Current mortgage rates as of June 17, 2024 - Yahoo Canada Finance
BNIXBannix Acquisition Corp. Latest Stock News & Market Updates - StockTitan
Bannix Acquisition Corp Stock (BNIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):